Cargando…

Evolution of resistance to MAPK-targeted therapies

Detalles Bibliográficos
Autor principal: Lo, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315230/
http://dx.doi.org/10.1186/1479-5876-13-S1-K2
_version_ 1782355442172690432
author Lo, Roger
author_facet Lo, Roger
author_sort Lo, Roger
collection PubMed
description
format Online
Article
Text
id pubmed-4315230
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43152302015-02-12 Evolution of resistance to MAPK-targeted therapies Lo, Roger J Transl Med Keynote Speaker Presentation BioMed Central 2015-01-15 /pmc/articles/PMC4315230/ http://dx.doi.org/10.1186/1479-5876-13-S1-K2 Text en Copyright © 2015 Lo; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Keynote Speaker Presentation
Lo, Roger
Evolution of resistance to MAPK-targeted therapies
title Evolution of resistance to MAPK-targeted therapies
title_full Evolution of resistance to MAPK-targeted therapies
title_fullStr Evolution of resistance to MAPK-targeted therapies
title_full_unstemmed Evolution of resistance to MAPK-targeted therapies
title_short Evolution of resistance to MAPK-targeted therapies
title_sort evolution of resistance to mapk-targeted therapies
topic Keynote Speaker Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315230/
http://dx.doi.org/10.1186/1479-5876-13-S1-K2
work_keys_str_mv AT loroger evolutionofresistancetomapktargetedtherapies